Global Bio-chem Technology Group Company Limited
Global Bio-chem Technology Group Company Limited, an investment holding company, manufactures and sells corn refined products and corn-based biochemical products in the People's Republic of China, rest of Asia, the Americas, and internationally. It operates through four segments: Upstream Products, Amino Acids, Corn Sweeteners, and Polyol Chemicals. The company offers corn refined products, inclu… Read more
Global Bio-chem Technology Group Company Limited (GBCMY) - Total Liabilities
Latest total liabilities as of June 2025: $6.89 Billion USD
Based on the latest financial reports, Global Bio-chem Technology Group Company Limited (GBCMY) has total liabilities worth $6.89 Billion USD as of June 2025.
Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
Global Bio-chem Technology Group Company Limited - Total Liabilities Trend (2000–2024)
This chart illustrates how Global Bio-chem Technology Group Company Limited's total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.
Global Bio-chem Technology Group Company Limited Competitors by Total Liabilities
The table below lists competitors of Global Bio-chem Technology Group Company Limited ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Global Atomic Corp
OTCQX:GLATF
|
USA | $35.64 Million |
|
SKS Technologies Group Ltd
AU:SKS
|
Australia | AU$85.82 Million |
|
Chengdu Rainbow Appliance Gr
SHE:003023
|
China | CN¥513.98 Million |
|
Jai Balaji Industries Limited
NSE:JAIBALAJI
|
India | ₹17.23 Billion |
|
ST George Mining Ltd
AU:SGQ
|
Australia | AU$21.81 Million |
|
IBASE Technology
TWO:8050
|
Taiwan | NT$4.38 Billion |
|
Deceuninck
BR:DECB
|
Belgium | €373.19 Million |
Liability Composition Analysis (2000–2024)
This chart breaks down Global Bio-chem Technology Group Company Limited's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 0.35 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | -3.12 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 1.47 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Global Bio-chem Technology Group Company Limited's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Global Bio-chem Technology Group Company Limited (2000–2024)
The table below shows the annual total liabilities of Global Bio-chem Technology Group Company Limited from 2000 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-12-31 | $6.50 Billion | -29.74% |
| 2023-12-31 | $9.25 Billion | -32.20% |
| 2022-12-31 | $13.64 Billion | +3.44% |
| 2021-12-31 | $13.18 Billion | -3.20% |
| 2020-12-31 | $13.62 Billion | +8.25% |
| 2019-12-31 | $12.58 Billion | -6.08% |
| 2018-12-31 | $13.40 Billion | +1.25% |
| 2017-12-31 | $13.23 Billion | +13.68% |
| 2016-12-31 | $11.64 Billion | -7.32% |
| 2015-12-31 | $12.56 Billion | +0.46% |
| 2014-12-31 | $12.50 Billion | -8.70% |
| 2013-12-31 | $13.69 Billion | +17.05% |
| 2012-12-31 | $11.70 Billion | -1.62% |
| 2011-12-31 | $11.89 Billion | +16.98% |
| 2010-12-31 | $10.16 Billion | +13.27% |
| 2009-12-31 | $8.97 Billion | +18.96% |
| 2008-12-31 | $7.54 Billion | +15.82% |
| 2007-12-31 | $6.51 Billion | +17.82% |
| 2006-12-31 | $5.53 Billion | +18.49% |
| 2005-12-31 | $4.66 Billion | +110.02% |
| 2004-12-31 | $2.22 Billion | +56.97% |
| 2003-12-31 | $1.41 Billion | +108.60% |
| 2002-12-31 | $678.31 Million | +12.21% |
| 2001-12-31 | $604.53 Million | -26.86% |
| 2000-12-31 | $826.56 Million | -- |